Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL530900 | 0.78 | ALOX5 (0.42) | GABRA1GABRB2KDM4EALDH1A1ALOX5 | |
| Acetic Acid SCHEMBL1657269 | 0.78 | PTGS1 (0.44) | TRPV1GABRA1GABRB2KDM4EALDH1A1 | |
| SCHEMBL2843447 | 0.77 | ALOX5 (0.46) | GABRA1GABRB2GABRA5GABRA3GABRA2 | |
| Acetic Acid SCHEMBL28484580 | 0.77 | ALOX5 (0.41) | GABRA1GABRB2KDM4EALDH1A1ALOX5 | |
| SCHEMBL310587 | 0.77 | ALOX5 (0.49) | GABRA1GABRB2GABRA5GABRA3GABRA2 | |
| SCHEMBL9279198 | 0.76 | HSD17B10 (0.53) | GABRA1GABRB2GABRA5GABRA3GABRA2 | |
| SCHEMBL28373317 | 0.75 | GABRA1 (0.44) | TRPV1GABRA1GABRB2ALDH1A1ALOX5 | |
| SCHEMBL1173287 | 0.75 | ALOX5 (0.44) | GABRA1GABRB2ALDH1A1ALOX5CYP3A4 | |
| SCHEMBL132917 | 0.74 | ALOX5 (0.46) | GABRA1GABRB2KDM4EALDH1A1ALOX5 | |
| SCHEMBL1869397 | 0.74 | ALOX5 (0.46) | GABRA1GABRB2KDM4EALDH1A1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240099995-A1 | METHOD OF PREPARING A TOPICAL PHARMACEUTICAL COMPOSITION | PHEBRA PTY LTD (AU) | 2024-03-28 | — | — | US | claimed |
| EP-4291171-A1 | METHOD OF PREPARING A TOPICAL PHARMACEUTICAL COMPOSITION | Phebra Pty Ltd (AU) | 2023-12-20 | — | — | EP | claimed |
| WO-2006127024-A1 | REAGENTS AND METHODS FOR LABELING TERMINAL OLEFINS | EISAI CO. LTD. (JP) | 2006-11-30 | — | — | WO | claimed |
| US-20060045846-A1 | Reagents and methods for labeling terminal olefins | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2006-03-02 | — | — | US | claimed |
| US-20050152957-A1 | Compositions and delivery systems for administration of a local anesthetic agent | CORIUM INTERNATIONAL (US) | 2005-07-14 | — | — | US | claimed |
| US-20030027833-A1 | Compositions and delivery systems for administration of a local anesthetic agent | CORIUM INTERNATIONAL, INC. | 2003-02-06 | — | — | US | claimed |
| WO-2002089849-A1 | COMPOSITIONS AND DELIVERY SYSTEMS FOR ADMINISTRATION OF A LOCAL ANESTHETIC AGENT | CORIUM INTERNATIONAL (US) | 2002-11-14 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-4736898-A2 | NANOFIBER-HYDROGEL COMPOSITES FOR ENHANCED SOFT TISSUE REPLACEMENT AND REGENERATION | The Johns Hopkins University (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260102540-A1 | NANOFIBER-HYDROGEL COMPOSITES AND METHODS FOR INHIBITING ADHESION FORMATION | UNIV JOHNS HOPKINS (US) | 2026-04-16 | — | — | US | disclosed |
| US-12544489-B2 | Fiber-hydrogel composite surgical meshes for tissue repair | THE JOHNS HOPKINS UNIVERSITY (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3790601-B1 | NANOFIBER-HYDROGEL COMPOSITES FOR ENHANCED SOFT TISSUE REPLACEMENT AND REGENERATION | UNIV JOHNS HOPKINS (US) | 2025-12-10 | — | — | EP | disclosed |
| US-12458731-B2 | Mesenchymal cell-binding composite material for tissue restoration | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-11-04 | — | — | US | disclosed |
| US-6024976-A | TRANSDERMAL DRUG DELIVERY WITH PRESSURE SENSITIVE ADHESIVE COMPOSITION OF POLYVINYLPYRROLIDONE WITH DRUG IN MULTILAYER PATCH | NOVEN PHARMACEUTICALS, INC. (US) | 2000-02-15 | — | — | US | disclosed |
| WO-1999015210-A2 | BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | disclosed |
| US-5719197-A | DRUG DELIVERY | NOVEN PHARMACEUTICALS, INC. (US) | 1998-02-17 | — | — | US | disclosed |
| US-5656286-A | BLEND OF TWO POLYMERS; PRESSURE SENSITIVE ADHESIVE | NOVEN PHARMACEUTICALS, INC. (US) | 1997-08-12 | — | — | US | disclosed |
| WO-1996040086-A2 | COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-5446070-A | Flexible, finite, bioadhesive, therapeutical agent in solid form | NOVER PHARMACEUTICALS, INC. (US) | 1995-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060045846-A1 | Reagents and methods for labeling terminal olefins | EEF2, RNF168, REL | TRPV1 4296/4885GABRA1 1206/4885GABRB2 2152/4885 |
| US-20260102540-A1 | NANOFIBER-HYDROGEL COMPOSITES AND METHODS FOR INHIBITING ADHESION FORMATION | NGF, CNTN1, PRPH | TRPV1 3646/4885GABRA1 3876/4885GABRB2 3404/4885 |
| US-12544489-B2 | Fiber-hydrogel composite surgical meshes for tissue repair | CD44, FGB, ILK | TRPV1 3749/4885GABRA1 2888/4885GABRB2 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.